Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease

Ryan, 1996, ACC/AHA guidelines for the management of patients with acute myocardial infarction, J Am Coll Cardiol, 28, 1328, 10.1016/S0735-1097(96)00392-0

Cowie, 1997, The epidemiology of heart failure, Eur Heart J, 18, 208, 10.1093/oxfordjournals.eurheartj.a015223

1997

1993, Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II), JAMA, 269, 3015, 10.1001/jama.1993.03500230097036

Smith, 1995, Preventing heart attack and death in patients with coronary disease, Circulation, 92, 2

Konstam, MA, Dracup, K, Baker DW, Bottorff MB, Brooks NH, Dacey RA, Dunbar SB, Jackson AB, Jessup M, Johnson JC, Jones RH, Luchi RJ, Massie BM, Pitt B, Rose EA, Rubin LJ, Wright RF, Hadorn DC. Heart failure: Management of patients with left-ventricular systolic dysfunction. Quick Reference Guide for Clinicians No. 11. AHCPR Publication 94- 0613. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services. June 1994.

1995, Guidelines for the evaluation and management of heart failure, J Am Coll Cardiol, 25, 1376

Stafford, 1997, Variations in cholesterol management practices of U.S. physicians, J Am Coll Cardiol, 29, 139, 10.1016/S0735-1097(96)00441-X

1995, Low incidence of assessment and modification of risk factors in acute care patients at high risk for cardiovascular events, particularly among females and the elderly, Am J Cardiol, 76, 570, 10.1016/S0002-9149(99)80157-X

Nieto, 1995, Population awareness and control of hypertension and hypercholesterolemia, Arch Intern Med, 155, 677, 10.1001/archinte.1995.00430070027003

Giles, 1993, Recent trends in the identification and treatment of high blood cholesterol by physicians, JAMA, 269, 1133, 10.1001/jama.1993.03500090069035

Cohen, 1991, Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease, Circulation, 83, 1294, 10.1161/01.CIR.83.4.1294

Hillis, 1995, Angiotensin-converting-enzyme inhibitors in the management of cardiac failure, Q J Med, 89, 145, 10.1093/qjmed/89.2.145

Philbin, 1996, Patterns of angiotensin converting enzyme inhibitor use in congestive heart failure in two community hospitals, Am J Cardiol, 77, 832, 10.1016/S0002-9149(97)89177-1

1997, Heart failure treatment with angiotensin converting enzyme inhibitors in hospitalized Medicare patients in 10 large states, Arch Int Med, 157, 1103, 10.1001/archinte.1997.00440310067007

Simpson, 1997, Performance assessment model for guideline-recommended pharmacotherapy in the secondary prevention of coronary artery disease and treatment of LV dysfunction, Am J Cardiol, 80, 53H, 10.1016/S0002-9149(97)00821-7

1997 Physicians Desk Reference. Medical Economics Data Production Company, Montvale, NJ.

Illingworth, 1994, A review of clinical trials comparing HMG-CoA reductase inhibitors, Clinical Therapeutics, 16, 366

1997, ASHP Therapeutic guidelines on angiotensin-converting-enzyme inhibitors in patients with LV dysfunction, Am J Health-Syst Pharm, 54, 299, 10.1093/ajhp/54.3.299

1988, Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults, Arch Intern Med, 148, 36, 10.1001/archinte.1988.00380010040006

Northridge, 1994, Inadequate management of hyperlipidaemia after coronary bypass surgery shown by medical audit, Br Heart J, 72, 466, 10.1136/hrt.72.5.466

Merz, 1996, Cholesterol awareness and treatment in patients with coronary artery disease participating in cardiac rehabilitation, J Cardiopulmonary Rehabil, 16, 117, 10.1097/00008483-199603000-00006

1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease, Lancet, 344, 1383

Sacks, 1996, The effect of pravastatin in patients with average cholesterol levels, N Engl J Med, 3335, 1001, 10.1056/NEJM199610033351401

Marcelino, 1996, Inadequate treatment with HMG-CoA reductase inhibitors by health care providers, Am J Med, 100, 605, 10.1016/S0002-9343(96)00011-3

Schrott, 1997, Adherence to national cholesterol education program treatment goals in postmenopausal women with heart disease, JAMA, 277, 1281, 10.1001/jama.1997.03540400031027

Havranek, 1996, Process and outcome of outpatient management of heart failure, Am J Man Care, 2, 783

Young, 1995, Patterns of medication use in patients with heart failure, Southern Med J, 88, 514, 10.1097/00007611-199505000-00002

Croft, 1997, Pharmacologic management of older adults by office-based physicians in the United States, J Fam Pract, 44, 382